Austar Lifesciences Limited (HKG:6118)
0.8200
0.00 (0.00%)
May 11, 2026, 4:08 PM HKT
Austar Lifesciences Market Cap
Austar Lifesciences has a market cap or net worth of 420.32 million as of May 11, 2026. Its market cap has increased by 5.13% in one year.
Market Cap
420.32M
Enterprise Value
551.43M
Revenue
1.70B
Ranking
n/a
PE Ratio
11.17
Stock Price
0.82
Market Cap Chart
Since November 7, 2014, Austar Lifesciences's market cap has decreased from 1.79B to 420.32M, a decrease of -76.45%. That is a compound annual growth rate of -11.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 420.32M | -5.75% |
| Dec 31, 2025 | 445.95M | 52.63% |
| Dec 31, 2024 | 292.17M | -63.46% |
| Dec 29, 2023 | 799.63M | -22.77% |
| Dec 30, 2022 | 1.04B | -86.60% |
| Dec 31, 2021 | 7.73B | 147.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acotec Scientific Holdings | 2.94B |
| Shanghai HeartCare Medical Technology Corporation | 2.00B |
| Sisram Medical | 1.36B |
| Cryofocus Medtech (Shanghai) | 1.35B |
| Venus Medtech (Hangzhou) | 766.32M |
| Gaush Meditech | 742.62M |
| Vincent Medical Holdings | 580.27M |
| Broncus Holding | 553.43M |